April 14, 2024

The government dismissed the media reports claiming that medicine prices will witness a significant hike

New Delhi:

The government dismissed the media reports claiming that medicine prices will witness a significant hike by up to 12 per cent from April 2024 and called them false, misleading and malicious.

“Some media reports have highlighted that medicine prices will witness a significant hike by up to 12 per cent from April 2024. These reports further claim that more than 500 medicines will be affected by this increase in price. Such reports are false, misleading and malicious”, an official statement said.

As per the provisions of Drug Price Control Orders (DPCO) 2013, drugs are categorised as scheduled and non-scheduled formulations. The formulations that are listed in Schedule I of DPCO 2013 are scheduled formulations and the formulations that are not specified in Schedule I of DPCO 2013 are non-schedule formulations.

According to the Ministry of Health and Family Welfare, the National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals annually revises the ceiling prices of scheduled medicines based on the Wholesale Price Index (WPI).

The scheduled medicines included in the Schedule-I of the DPCO, 2013 are essential. During the calendar year 2023 over the corresponding period in 2022, the annual change in WPI with base year 2011-12 was ( ) 0.00551 per cent as per data published by the Department for Promotion of Industry and Internal Trade (DPIIT). Accordingly, the Authority in its meeting held on 20.03.2024 has approved the WPI increase @ ( ) 0.00551 per cent for the scheduled medicines.

The ceiling prices on 923 medicines are effective as of date. Based on the above-mentioned WPI factor of ( ) 0.00551 per cent, there will be no change in the prevailing ceiling prices for 782 medicines and the existing ceiling prices will continue to prevail up to March 31, 2025.

Fifty-four (54) medicines with ceiling prices ranging from Rs 90 to Rs 261 will have a miniscule increase of Rs. 0.01 (one paisa). As the permissible price increase is miniscule, the companies may or may not avail of this increase. Thus, in the year FY 2024-25, there will be almost no change in the ceiling price of medicines based on WPI.

The WPI increase is the maximum increase permissible as per the DPCO, 2013 and the manufacturers may or may not avail of this increase, keeping in view the market dynamics. The companies adjust their Maximum Retail Price (MRP) depending on the ceiling price of their medicines, as MRP (excluding GST) can be any price that is less than the ceiling price.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Batman138 Bro138 Dolar138 Gas138 Gudang138 Hoki99 Ligaciputra Panen77 Zeus138 Kilat77 Planet88 Gaspol168 Sikat88 Rupiah138 Garuda138 Gacor77 Roma77 Sensa138 Panen138 Slot138 Gaco88 Elanggame Candy99 Cair77 Max7 Best188 Space77 Sky77 Luxury777 Maxwin138 Bosswin168 Cocol88 Slot5000 Babe138 Luxury138 Jet77 Bonanza138 Bos88 Aquaslot Taktik88 Lord88 Indobet Slot69 Paus138 Tiktok88 Panengg Bingo4d Stars77 77dragon Warung168 Receh88 Online138 Tambang88 Asia77 Klik4d Bdslot88 Gajah138 Bigwin138 Markas138 Yuk69 Emas168 Key4d Harta138  Gopek178 Imbaslot Imbajp Deluna4d Luxury333 Pentaslot Luxury111 Cair77 Gboslot Pandora188 Olxtoto Slotvip Eslot Kuy138 Imbagacor Bimabet